MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Amedisys Inc

Cerrado

Sector Salud

90.39 -0.83

Resumen

Variación precio

24h

Actual

Mínimo

90.3

Máximo

90.5

Métricas clave

By Trading Economics

Ingresos

-16M

17M

Ventas

-3.5M

588M

P/B

Media del Sector

36.726

73.394

BPA

1

Margen de beneficio

2.81

Empleados

19,000

EBITDA

-46M

26M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+11.46 upside

Dividendos

By Dow Jones

Próximas Ganancias

25 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.6M

3B

Apertura anterior

91.22

Cierre anterior

90.39

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

157 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Amedisys Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 ene 2025, 23:27 UTC

Adquisiciones, fusiones, absorciones

UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring -- Update

8 ene 2025, 22:47 UTC

Adquisiciones, fusiones, absorciones

UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring

8 ene 2025, 21:57 UTC

Adquisiciones, fusiones, absorciones

UnitedHealth Group Terminates Deal for Sale of Certain Amedisys and UnitedHealth Assets to VitalCaring Group

27 dic 2024, 17:58 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal -- Barrons.com

12 nov 2024, 20:18 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Justice Department Sues to Block UnitedHealth's $3.3 Billion Bid for Amedisys -- Update

12 nov 2024, 19:34 UTC

Adquisiciones, fusiones, absorciones

DOJ Lawsuit Threatens to Derail UnitedHealth's Effort to Buy Another Home Health Provider -- Barrons.com

12 nov 2024, 17:42 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Justice Department Sues to Block UnitedHealth's $3.3 Billion Bid for Amedisys -- WSJ

Comparación entre iguales

Cambio de precio

Amedisys Inc Esperado

Precio Objetivo

By TipRanks

11.46% repunte

Estimación a 12 meses

Media 100.8 USD  11.46%

Máximo 101 USD

Mínimo 100 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Amedisys Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

6 ratings

1

Comprar

5

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 92.27Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Very Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

157 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Amedisys Inc

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.